Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) Resource Development OS, AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA NLM SNOMED CT (Systematized Nomenclature of Medicine - Clinical Terms), the standard nomenclature of medicine, is a comprehensive, precise, and multilingual health terminology system. It assists with the electronic exchange of clinical health information, can be mapped to other coding systems, and serves as a resource with extensive, scientifically validated clinical content. NLM serves as the United States National Release Center, is a member of SNOMED International, and is responsible for creating and distributing the US Edition of SNOMED CT. NLM also accepts content requests for inclusion in the US Edition of SNOMED CT. Collaborators, including the Department of Veterans Affairs, National Cancer Institute, Agency for Healthcare Research and Quality, CDC, Centers for Medicare & Medicaid Services, and FDA, have integrated SNOMED CT into their resources and submitted content requests for inclusion in the US Edition of SNOMED CT. https://www.nlm.nih.gov/healthit/snomedct/index.html
Task Force for Combating Antibiotic-Resistant Bacteria (CARB) Committee, Work group, Advisory group, or Task Force AHRQ, ASPR, CDC, CMS, FDA, HRSA NIAID Established by Executive Order 13676, the Task Force facilitates implementation of the CARB Action Plan and provides progress reports and quarterly updates describing key achievements. The Task Force is an internal government committee comprised of federal representatives and co-chaired by the Secretaries of Defense, Agriculture, and HHS.
Task Force on Maternal Mental Health Committee, Work group, Advisory group, or Task Force SAMHSA, ACF, ACL, AHRQ, ASPE, CDC, CMS, HRSA, IEA, IHS, OASH NICHD, NIMH The Task Force on Maternal Mental Health, co-led by the Office on Women’s Health and the Substance Abuse and Mental Health Services Administration (SAMHSA), will identify, evaluate, and make recommendations to coordinate and improve activities related to addressing maternal mental health conditions and co-occurring substance use disorders. There will be a focus on mental health equity as well as trauma-informed practices.Areas of FocusData, Research, Quality Improvement and Health EquityPrevention, Screening, and DiagnosisEvidence-based Intervention and TreatmentEvidence-based Community PracticesCommunications and Community Engagement
Technical Expert Panel on the Development of Evidence-Based Practice Guide on the Treatment of Serious Mental Illness (SMI) in Older Adults Meeting/ Workshop SAMHSA NIMH Substance Abuse and Mental Health Services Administration (SAMHSA) convened a technical expert panel to provide guidance on the development of an evidence-based practice guide on the treatment of serious mental illness in older adults. The guide is an important part of the 21st Century Cures Act's charge at SAMHSA to disseminate information on evidence-based practices and will address best practices for older adults.
Testing Risks of Artificial Intelligence for National Security (TRAINS) Taskforce Committee, Work group, Advisory group, or Task Force AHRQ, CDC, CMS, FDA, IHS, SAMHSA OD/OCIO Identify, measure, and manage the emerging national security and public safety implications of rapidly evolving AI technology
The Administration for Strategic Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense subject matter expert team Committee, Work group, Advisory group, or Task Force ASPR NCI, NIAID NCI and NIAID participate in Assistant Secretary for Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense team. Both NCI and NIAID provide expertise on radiation topics and for the Biomedical Advanced Research and Development Authority (BARDA), within the Office of ASPR in the U.S.
The Agricultural Health Study Research Initiative CDC NIEHS The Agricultural Health Study (AHS) is a prospective study of cancer and other health outcomes in a cohort of licensed pesticide applicators and their spouses from Iowa and North Carolina. The AHS began in 1993 with the goal of answering important questions about how agricultural, lifestyle and genetic factors affect the health of farming populations. 
The Cancer Cabinet Task Force for Prevention and Screening Committee, Work group, Advisory group, or Task Force CDC, CMS, FDA NCI In February 2022, President Biden kickstarted the next phase of the Cancer Moonshot with bold new goals: to reduce the cancer death rate by half within 25 years and improve the lives of people with cancer and cancer survivors. The following month, the White House convened the Cancer Cabinet, bringing together departments and agencies from across the federal government to establish a prioritized agenda across government, including the development of new interagency programs and collaborations. The Cancer Cabinet includes members from 20 executive branch departments, agencies, and offices.  Priority Actions for the Cancer Cabinet:Close the Screening Gap: Americans missed nearly 10 million cancer screenings as compared to prior years due to the COVID-19 pandemic. Through targeted and coordinated programs, we should cut that deficit by providing access to more cancer screening opportunities and expand equitable access to cancer early detection.Decrease the Impact of Preventable Cancers: Thanks to scientific advancements, there are more tools today than ever before to prevent cancer. There are also healthy lifestyle choices like nutrition, tobacco cessation, others as well as tools such as the HPV vaccine and Hepatitis C antivirals that can prevent cervical, head and neck, and liver cancer, respectively. Additionally, advances in colonoscopy technology enable detection and removal of pre-cancerous growths to prevent the development of colon cancer in more individuals. Additional efforts are needed to expand access to these cancer-prevention approaches along with public health campaigns and community health efforts to ensure these preventative tools are reaching all populations. In doing so, there is opportunity to nearly or wholly eliminate certain cancer types.
The Environmental Determinants of Diabetes in the Young (TEDDY) Research Initiative CDC NIAID, NICHD, NIDDK, NIEHS This consortium, established and funded by NIDDK, is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes.
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) Research Initiative CDC, FDA NCI, NHGRI, NHLBI, NIA, NIAID, NIEHS The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) initiative provides a unique infrastructure to obtain valuable data and samples to study Burkitt’s lymphoma (BL) epidemiology. Study data will help characterize or investigate: (1) The association of malaria-resistance genes with endemic BL. (2) Host genetic polymorphisms associated with BL using genome-wide association methods. (3) The role of the Epstein-Barr virus (EBV) genetic variants in endemic BL. (4) The role of malaria immunology and phenotype of inflammation in BL. (5) The complexity of coinfection with different P. falciparum malaria genotypes in BL. (6) The interaction between helminthic parasites, HIV, malaria, and EBV in BL. (7) The immunohistochemistry and molecular pathology of BL. (8) The impact of malaria, helminthic parasites, and HIV on childhood BL.